Cargando…
E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?
Loss of heterozygosity at the long arm of chromosome 16 is one of the most frequent genetic events in breast cancer. In the search for tumour suppressor genes that are the target of loss of heterozygosity at 16q, the E-cadherin gene CDH1 was unveiled by the identification of truncating mutations in...
Autor principal: | Cleton-Jansen, Anne-Marie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138715/ https://www.ncbi.nlm.nih.gov/pubmed/11879552 http://dx.doi.org/10.1186/bcr416 |
Ejemplares similares
-
Loss of heterozygosity on chromosome arm 16q in breast cancer: clinical, molecular and statistical approaches
por: Cleton-Jansen, A-M, et al.
Publicado: (2000) -
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
por: Vos, C. B., et al.
Publicado: (1997) -
Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer
por: Huiping, C, et al.
Publicado: (1999) -
Analysis of chromosome alterations and the E-cadherin and FHIT genes in lobular breast cancer
por: Ingvarsson, S, et al.
Publicado: (2000) -
Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast.
por: Marsh, K. L., et al.
Publicado: (1998)